Indies Pharma Jamaica Limited reported earnings results for the full year ended October 31, 2022. For the full year, the company reported sales was JMD 937.28 million compared to JMD 846.83 million a year ago. Net income was JMD 220.79 million compared to JMD 167.87 million a year ago.

Basic earnings per share from continuing operations was JMD 0.17 compared to JMD 0.13 a year ago.